Literature DB >> 22049303

Association of contrast sensitivity with LogMAR visual acuity and glycosylated hemoglobin in non-insulin dependent diabetes mellitus.

Shaili Misra, Sandeep Saxena, Poonam Kishore, Shashi K Bhasker, Arvind Misra, Carsten H Meyer.   

Abstract

A tertiary care center-based prospective case-control study was undertaken to evaluate the association of contrast sensitivity with LogMAR visual acuity and glycosylated hemoglobin (HbA1c) in 205 cases of non-insulin dependent diabetes mellitus and 115 controls. LogMAR visual acuity and contrast sensitivity were scored using ETDRS and Pelli-Robson charts, respectively. Bivariate correlation between contrast sensitivity and LogMAR visual acuity showed significant inverse correlation in cases without retinopathy (r = -0.466) and with non-proliferative retinopathy (r = -0.307). In a multivariate model, on applying linear regression analysis, LogMAR visual acuity (p < 0.001) and HbA1c (p = 0.002) had significant association with contrast sensitivity. Significant difference in contrast sensitivity was not observed between cases without diabetic retinopathy and with non-proliferative diabetic retinopathy, implying no association with retinal microvascular changes. Contrast sensitivity dysfunction observed in diabetes mellitus results from changes in retinal function secondary to alteration in carbohydrate metabolism depicted in glycosylated hemoglobin.

Entities:  

Keywords:  Contrast sensitivity; Glycosylated hemoglobin; LogMAR visual acuity; Non-insulin dependent diabetes mellitus

Year:  2010        PMID: 22049303      PMCID: PMC3148141          DOI: 10.1007/s12177-010-9056-0

Source DB:  PubMed          Journal:  J Ocul Biol Dis Infor        ISSN: 1936-8437


  14 in total

1.  Spatial frequency-selective losses with pattern electroretinogram in type 1 (insulin-dependent) diabetic patients without retinopathy.

Authors:  M A Di Leo; B Falsini; S Caputo; G Ghirlanda; V Porciatti; A V Greco
Journal:  Diabetologia       Date:  1990-12       Impact factor: 10.122

2.  New visual acuity charts for clinical research.

Authors:  F L Ferris; A Kassoff; G H Bresnick; I Bailey
Journal:  Am J Ophthalmol       Date:  1982-07       Impact factor: 5.258

3.  Risk factors associated with contrast sensitivity loss in diabetic patients.

Authors:  A A Dosso; E R Bonvin; Y Morel; A Golay; J P Assal; P M Leuenberger
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-05       Impact factor: 3.117

4.  [Contrast sensitivity and diabetes].

Authors:  J P Nordmann; A Guigui; L Laroche; P Denis; H Saraux
Journal:  Bull Soc Ophtalmol Fr       Date:  1990-05

5.  Contrast sensitivity in diabetics with and without background retinopathy.

Authors:  S Sokol; A Moskowitz; B Skarf; R Evans; M Molitch; B Senior
Journal:  Arch Ophthalmol       Date:  1985-01

6.  Contrast sensitivity in obese dyslipidemic patients with insulin resistance.

Authors:  A A Dosso; F Yenice-Ustun; J Sommerhalder; A Golay; Y Morel; P M Leuenberger
Journal:  Arch Ophthalmol       Date:  1998-10

7.  A simple grating test for contrast sensitivity: preliminary results indicate value in screening for glaucoma.

Authors:  G B Arden; J J Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-01       Impact factor: 4.799

8.  Abnormal Cambridge low-contrast grating sensitivity results associated with diabetic retinopathy as a potential screening tool.

Authors:  M Abrishami; J Heravian; A Derakhshan; M Mousavi; T Banaee; R Daneshvar; H O Moghaddam
Journal:  East Mediterr Health J       Date:  2007 Jul-Aug       Impact factor: 1.628

9.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

10.  Letter contrast sensitivity changes in early diabetic retinopathy.

Authors:  Efty P Stavrou; Joanne M Wood
Journal:  Clin Exp Optom       Date:  2003-05       Impact factor: 2.742

View more
  9 in total

1.  Contrast sensitivity and its determinants in people with diabetes: SN-DREAMS-II, Report No 6.

Authors:  L Gella; R Raman; S S Pal; S Ganesan; T Sharma
Journal:  Eye (Lond)       Date:  2016-11-18       Impact factor: 3.775

2.  Diabetic brain or retina? Visual psychophysical performance in diabetic patients in relation to GABA levels in occipital cortex.

Authors:  Mafalda Sanches; Sulaiman I Abuhaiba; Otília C d'Almeida; Bruno Quendera; Leonor Gomes; Carolina Moreno; Daniela Guelho; Miguel Castelo-Branco
Journal:  Metab Brain Dis       Date:  2017-03-30       Impact factor: 3.584

Review 3.  Psychophysical Exams as Early Indicators of Diabetic Retinopathy.

Authors:  Nicola Pescosolido; Giuseppe Buomprisco
Journal:  Eur Endocrinol       Date:  2014-02-28

4.  Contrast sensitivity is associated with outer-retina thickness in early-stage diabetic retinopathy.

Authors:  J Jason McAnany; Jason C Park; Karen Liu; Michelle Liu; Yi-Fan Chen; Felix Y Chau; Jennifer I Lim
Journal:  Acta Ophthalmol       Date:  2019-09-13       Impact factor: 3.761

5.  Functional retinal outcomes in patients with prediabetes and type 2 diabetes.

Authors:  Nicole Karson; Jennyffer Smith; Morgan Jones; Ananya Datta; Kathryn Richdale; Wendy W Harrison
Journal:  Ophthalmic Physiol Opt       Date:  2020-09-21       Impact factor: 3.117

6.  Effect of Initial Aflibercept, Laser, or Observation on Low-Contrast Visual Acuity in Eyes With Diabetic Macular Edema and Good Vision: Ancillary Study Within a Randomized Clinical Trial.

Authors:  Wesley T Beaulieu; Adam R Glassman; Carl W Baker; Maureen G Maguire; Chris A Johnson; Michele Melia; Jennifer K Sun
Journal:  Transl Vis Sci Technol       Date:  2021-03-01       Impact factor: 3.048

Review 7.  A critical review: Psychophysical assessments of diabetic retinopathy.

Authors:  Xing D Chen; Thomas W Gardner
Journal:  Surv Ophthalmol       Date:  2020-08-29       Impact factor: 6.048

8.  Influence of retinopathy on the achromatic and chromatic vision of patients with type 2 diabetes.

Authors:  Luciana Cristina O Andrade; Givago S Souza; Eliza Maria C B Lacerda; Maira Tst Nazima; Anderson R Rodrigues; Liudmila M Otero; Francineide Ps Pena; Luiz Carlos L Silveira; Maria Izabel T Côrtes
Journal:  BMC Ophthalmol       Date:  2014-08-31       Impact factor: 2.209

9.  Pilot Study on Visual Function and Fundus Autofluorescence Assessment in Diabetic Patients.

Authors:  Ana M Calvo-Maroto; José J Esteve-Taboada; Rafael J Pérez-Cambrodí; David Madrid-Costa; Alejandro Cerviño
Journal:  J Ophthalmol       Date:  2016-02-10       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.